Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
CEO Scotte Hudsmith’s View on Specialized Dental Partners’s Acquisition Strategy
Specialized Dental Partners (SDP) is one of the most active buyers in the dental practice market, announcing multiple transactions per year. A portfolio company of Quad-C Management, SDP is a leading specialty dental service organization that provides comprehensive support services to endodontic specialists across the United States. According to data captured in the LevinPro HC database, the dental industry is experiencing a slight increase in deal volume. In the first quarter of 2026, 62 dental transactions were publicly announced, a small increase from the 59 reported in both Q4:25 and Q1:25. However, there was a 6% drop between full year 2024 (267 deals) and full year 2025 (251 deals).... Read More »
Neurocrine Acquires Soleno Therapeutics for $2.9 Billion
On April 6, Neurocrine Biosciences, Inc. reported that it was expanding its endocrinology and rare disease portfolio with the purchase of Soleno Therapeutics, Inc. Neurocrine Biosciences will acquire Soleno Therapeutics for $53.00 per share in cash, representing a total transaction equity value of $2.9 billion. Soleno Therapeutics is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s first commercial product, VYKAT XR (diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and... Read More »
Noom Acquires 503A Compounding Pharmacy Tailor Made Compounding
Weight-loss company Noom has acquired 503A pharmacy Tailor Made Compounding, according to an April 1 press release. Noom Tailor Made Compounding is a 503A pharmacy that provides sterile and non-sterile compounding through its pharmacy practice focused on aging. It offers compounded drugs, including hormone replacement therapies and peptide therapies, as well as pharmacist-formulated supplements and cosmetics. The company works in men’s and women’s health, weight management, anti-aging and IV therapy, and touts a customer base of more than 400 clinics and numerous telehealth partners. It also has a compounding facility that is more than... Read More »
Premier Radiology Buys Teleradiology Group Global Imaging Solutions
Premier Radiology Services announced the acquisition of Global Imaging Solutions, also called GLOBIS. Financial terms of the deal were not disclosed. Global Imaging Solutions, also called GLOBIS, is a teleradiology group providing subspecialty imaging interpretations to outpatient imaging centers and orthopedic practices and physician-owned groups. The physician-founded company delivers approximately 350,000 reads annually. Founded in 2006, Premier Radiology Services is one of the top independent teleradiology solutions in the United States. Premier provides reliable and accurate interpretations of medical images to patients in 48 states through its technology-enabled platform. With a... Read More »
Vision Innovation Partners Expands in Maryland
Vision Innovation Partners (VIP) has expanded its Maryland presence with the acquisition of Frederick Eye Institute. Frederick Eye Institute, based in Frederick, Maryland, is a comprehensive ophthalmology practice. It specializes in cataract surgery and lens implants. The practice also employs the latest technology to provide care for glaucoma, macular degeneration, cataracts and dry eyes, as well as routine eye exams. According to its website, the practice is run by Dr. Robert Bruce Hodges. Founded in 2017 and headquartered in Annapolis, Maryland, VIP operates a network of ophthalmology service providers in the Mid-Atlantic region. VIP’s... Read More »
Citizens Advises Lync Health Partners on its Majority Recapitalization
Citizens Capital Markets & Advisory has served as exclusive financial advisor to Lync Health Partners on its majority recapitalization by United Surgical Partners International. Citizens Capital Markets & Advisory is part of the institutional broker-dealer, Citizens JMP Securities, LLC, a subsidiary of Citizens Financial Group. Lync Health Partners is an orthopedic ambulatory surgery center with a complementary management services organization and orthopedic walk-in clinic. Lync Health Partners was previously majority-owned by Atlanta, Georgia-based MSouth Equity Partners. United Surgical Partners International, a subsidiary of Tenet Healthcare, owns and operates more than 535... Read More »
Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion
Eli Lilly and Company announced on March 31 that it will be acquiring Boston- and London-based Centessa Pharmaceuticals. Centessa Pharmaceuticals is a clinical-stage pharmaceutical company developing a new class of drugs for the treatment of excessive daytime sleepiness and other neurological conditions. Centessa’s lead program is cleminorexton, formerly known as ORX750, which is undergoing a phase 2 study for two types of narcolepsy as well as idiopathic hypersomnia. Eli Lilly is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Eli Lilly discovers, develops, manufactures and sells pharmaceutical products worldwide. Its products... Read More »
Sidelined Capital: A Healthcare Webinar Wrap Up
Earlier in March, Ben Swett, Managing Editor of The SeniorCare Investor, was joined by John Tiedmann, Managing Director at Physician Growth Partners, Bill Hoffman, Shareholder at Polsinelli and Matt Bogle, Managing Director at Intrinsic, to examine key factors fueling and impeding healthcare services M&A deal volume. In a follow-up to our previously posted webinar wrap-up, we’re discussing the panelists’ perspectives on the different healthcare verticals, their headwinds/tailwinds and impact on the market. BEHAVIORAL HEALTH Although the Behavioral Healthcare (BHC) market saw a leading 44% surge in activity from 2024 to 2025, deal volume still trailed expectations given the... Read More »A New Normal? Q1:26 Healthcare M&A Stalls
According to data captured in our LevinPro HC platform, healthcare M&A stalled in the first quarter of 2026, reaching only 527 deals, a modest 3% dip compared with the fourth quarter. The difference in volume is small enough to feel almost arbitrary, but these slight quarter-over-quarter variations have become the norm over the past 24 months. As you can see in the chart below, deal volume has remained remarkably stable, aside from outliers in Q1:25 and Q3:25, each with deal activity exceeding 550 transactions. Source: LevinPro HC, March 2026 The steady deal volume suggests that the headwinds and tailwinds from 2024 and 2025 continue to steer the market. We suspect one reason deal... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
